Guardant and MSD will evaluate opportunities to develop new oncology therapies using liquid biopsy tests.

SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration ...

MSD and the Coalition for Epidemic Preparedness Innovations have launched a $30 million initiative to improve the ...

In 2025 alone, MSD acquired infectious disease specialist Cidara Therapeutics for $9.2 billion, respiratory drug developer ...

MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 billion (approximately 26 trillion Korean won), ranking first among global ...

MSD awaits 20 potential launches and 80 late-stage readouts across its pipeline, which it believes will double $35bn ...